1887

Chapter 71 : Varicella-Zoster Virus

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

Varicella-Zoster Virus, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815905/9781555813642_Chap71-1.gif /docserver/preview/fulltext/10.1128/9781555815905/9781555813642_Chap71-2.gif

Abstract:

Laboratory diagnosis of varicella-zoster virus (VZV) infection requires the identification of the virus or one of its products in skin lesions, tissues, or fluids from the patient. Techniques include isolation of the virus in tissue culture, direct immunofluorescent staining of cells obtained from lesions, and detection of the virus genome by techniques based on PCR. Vesicular fluids, crusts that have been ground in water, or skin lesion sections can be examined by electron microscopy (EM). The authors had experience of successful identification and typing of VZV strains from environmental swabs. Recent studies indicate that while multiple polymorphisms were identified between vaccine and wild-type strains, detection of the sequence polymorphism at genome position 106262 is the most reliable method for discriminating the vaccine strain from wild-type VZV. Perhaps the most important concern in the use of PCR is the quality of the template to be amplified. Serologic testing is most often requested for determining susceptibility to VZV in outbreak settings, but on occasion it is needed for diagnosis. Assay formats used for simple determination of VZV serostatus include enzyme-linked immunosorbent assay (ELISA), membrane fluorescence, and latex bead agglutination. Each of these test formats has limitations, which are discussed in this chapter. The authors recently documented cases of varicella in health care workers who were incorrectly identified as VZV seropositive by the latex bead agglutination method. Despite VZV immunoglobulin (VZIG) prophylaxis, approximately two-thirds of infants exposed to maternal varicella around the time of delivery will become infected.

Citation: Schmid D, Loparev V. 2006. Varicella-Zoster Virus, p 631-636. In Detrick B, Hamilton R, Folds J (ed), Manual of Molecular and Clinical Laboratory Immunology, 7th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815905.ch71

Key Concept Ranking

Restriction Fragment Length Polymorphism
0.46826887
0.46826887
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555815905.ch71
1. Arao, Y.,, D. S. Schmid,, P. F. Pellett, and , N. Inoue. 1999. Herpesviruses beyond HSV-1 and -2. Clin. Microbiol. Newsl. 21:153160.
2. Behrman, A.,, D. S. Schmid,, A. Crivaro, and , B. Watson. 2003. A cluster of primary varicella cases among healthcare workers with false-positive varicella-zoster virus titers. Infect. Control Hosp. Epidem. 24:202206.
3. Galil, K.,, G. P. Mootrey,, J. Seward, and , M. Wharton. 1999. Prevention of varicella: update recommendations of the Advisory Committee on Immunization Practices. Morbid. Mortal. Wkly. Rep. 48:15.
4. Loparev, V. N.,, T. Argaw,, P. R. Krause,, M. Takayama, and , D. S. Schmid. 2000. Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR. J. Clin. Microbiol. 38:31563160.
5. Loparev, V. N.,, A. Gonzalez,, M. Deleon-Carnes,, G. Tipples,, H. Fickenscher,, E. G. Torfason, and , D. S. Schmid. 2004. Three major genotypes of varicella-zoster virus: geographical clustering and strategies for genotyping. J. Virol. 78:83498358.
6. Loparev, V. N.,, K. McCaustland,, B. P. Holloway,, P. R. Krause,, M. Takayama, and , D. S. Schmid. 2000. Rapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probes. J. Clin. Microbiol. 38:43154319.
7. Martin, K.,, A. K. Junker,, E. F. Thomas,, M. I. Van Allen, and , M. M. Friedman. 1994. Occurrence of chickenpox during pregnancy in women seropositive for varicella-zoster virus. J. Infect. Dis. 170:991995.
8. Provost, P. J.,, D. L. Krah,, B. J. Kuter,, D. H. Morton,, T. L. Schofield,, E. H. Wasmuth,, C. J. White,, W. J. Miller, and , R. W. Ellis. 1991. Antibody assays suitable for assessing immune responses to live varicella vaccine. Vaccine 9:111116.
9. Seward, J. F.,, B. M. Watson,, C. L. Peterson,, L. Mascola,, J. W. Pelosi,, J. X. Zhang,, T. J. Maupin,, G. S. Goldman,, L. J. Tabony,, K. G. Brodovicz,, A. O. Jumaan, and , M. Wharton. 2002. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 287:606611.
10. Zaia, J. A., and , M. N. Oxman. 1977. Antibody to varicella-zoster virus-induced membrane antigen: immunofluores-cence assay using monodisperse glutaraldehyde-fixed target cells. J. Infect. Dis. 156:519530.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error